SEC Filing Update: #QNCX Quince Therapeutics, Inc. : $34.04

Sector: Healthcare | YTD: 🔽 -94.33% The SEC disclosed Today (14-AUG-2026) that IKARIAN CAPITAL, LLC has INCREASED #QNCX Shares by 27.04% 🟢 BALYASNY ASSET MANAGEMENT LLC also reported an increase in its holdings on the same day. CORMORANT ASSET MANAGEMENT, LP also reported an increase in its holdings on the same day. * Previous Holdings: 72.25K Shares * Current Holdings: 91.79K Shares * Increase+19.54K * Increased(%)+27.04% * Ownership: 9.0% * Estimated Investment Value: $591.42K https://www.thinksabio.com/reports/isr/QNCX 📌 Institutional activity in the last 30 days for #QNCX: • BALYASNY ASSET MANAGEMENT LLC – Increased holdings by 27,732 shares (14-AUG-2026) • CORMORANT ASSET MANAGEMENT, LP – Increased holdings by 102,531 shares (14-AUG-2026)